BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 22941189)

  • 1. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
    Rudin CM; Durinck S; Stawiski EW; Poirier JT; Modrusan Z; Shames DS; Bergbower EA; Guan Y; Shin J; Guillory J; Rivers CS; Foo CK; Bhatt D; Stinson J; Gnad F; Haverty PM; Gentleman R; Chaudhuri S; Janakiraman V; Jaiswal BS; Parikh C; Yuan W; Zhang Z; Koeppen H; Wu TD; Stern HM; Yauch RL; Huffman KE; Paskulin DD; Illei PB; Varella-Garcia M; Gazdar AF; de Sauvage FJ; Bourgon R; Minna JD; Brock MV; Seshagiri S
    Nat Genet; 2012 Oct; 44(10):1111-6. PubMed ID: 22941189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.
    Tenjin Y; Matsuura K; Kudoh S; Usuki S; Yamada T; Matsuo A; Sato Y; Saito H; Fujino K; Wakimoto J; Ichimura T; Kohrogi H; Sakagami T; Niwa H; Ito T
    Lab Invest; 2020 Dec; 100(12):1575-1588. PubMed ID: 32801334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.
    Iwakawa R; Takenaka M; Kohno T; Shimada Y; Totoki Y; Shibata T; Tsuta K; Nishikawa R; Noguchi M; Sato-Otsubo A; Ogawa S; Yokota J
    Genes Chromosomes Cancer; 2013 Sep; 52(9):802-16. PubMed ID: 23716474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma.
    Qin J; Xie F; Li C; Han N; Lu H
    Pathol Oncol Res; 2021; 27():1609775. PubMed ID: 34257619
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Voigt E; Wallenburg M; Wollenzien H; Thompson E; Kumar K; Feiner J; McNally M; Friesen H; Mukherjee M; Afeworki Y; Kareta MS
    Mol Cancer Res; 2021 Dec; 19(12):2015-2025. PubMed ID: 34593608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.
    Zhou H; Hu Y; Luo R; Zhao Y; Pan H; Ji L; Zhou T; Zhang L; Long H; Fu J; Wen Z; Wang S; Wang X; Lin P; Yang H; Wang J; Song M; Yi X; Yang L; Xia X; Guan Y; Fang W; Yang Y; Hong S; Huang Y; Li P; Zhang Y; Zhou N
    Nat Commun; 2021 Sep; 12(1):5431. PubMed ID: 34521849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET mutation and expression in small-cell lung cancer.
    Dabir S; Babakoohi S; Kluge A; Morrow JJ; Kresak A; Yang M; MacPherson D; Wildey G; Dowlati A
    J Thorac Oncol; 2014 Sep; 9(9):1316-23. PubMed ID: 25122427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.
    Ciampricotti M; Karakousi T; Richards AL; Quintanal-Villalonga À; Karatza A; Caeser R; Costa EA; Allaj V; Manoj P; Spainhower KB; Kombak FE; Sanchez-Rivera FJ; Jaspers JE; Zavitsanou AM; Maddalo D; Ventura A; Rideout WM; Akama-Garren EH; Jacks T; Donoghue MTA; Sen T; Oliver TG; Poirier JT; Papagiannakopoulos T; Rudin CM
    Cancer Discov; 2021 Dec; 11(12):3214-3229. PubMed ID: 34344693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.
    Tripathi SC; Fahrmann JF; Celiktas M; Aguilar M; Marini KD; Jolly MK; Katayama H; Wang H; Murage EN; Dennison JB; Watkins DN; Levine H; Ostrin EJ; Taguchi A; Hanash SM
    Cancer Res; 2017 Aug; 77(16):4414-4425. PubMed ID: 28646020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing.
    Su S; Zou JJ; Zeng YY; Cen WC; Zhou W; Liu Y; Su DH; Zhang XL; Huang HY; Lei A; Huang ZH; Jin Y; Li L; Su N; Xie YL; Zhao ZG; Liu JX
    Biomed Res Int; 2019; 2019():6096350. PubMed ID: 31781628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
    Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
    Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
    Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
    Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).
    Augert A; Zhang Q; Bates B; Cui M; Wang X; Wildey G; Dowlati A; MacPherson D
    J Thorac Oncol; 2017 Apr; 12(4):704-713. PubMed ID: 28007623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
    Peifer M; Fernández-Cuesta L; Sos ML; George J; Seidel D; Kasper LH; Plenker D; Leenders F; Sun R; Zander T; Menon R; Koker M; Dahmen I; Müller C; Di Cerbo V; Schildhaus HU; Altmüller J; Baessmann I; Becker C; de Wilde B; Vandesompele J; Böhm D; Ansén S; Gabler F; Wilkening I; Heynck S; Heuckmann JM; Lu X; Carter SL; Cibulskis K; Banerji S; Getz G; Park KS; Rauh D; Grütter C; Fischer M; Pasqualucci L; Wright G; Wainer Z; Russell P; Petersen I; Chen Y; Stoelben E; Ludwig C; Schnabel P; Hoffmann H; Muley T; Brockmann M; Engel-Riedel W; Muscarella LA; Fazio VM; Groen H; Timens W; Sietsma H; Thunnissen E; Smit E; Heideman DA; Snijders PJ; Cappuzzo F; Ligorio C; Damiani S; Field J; Solberg S; Brustugun OT; Lund-Iversen M; Sänger J; Clement JH; Soltermann A; Moch H; Weder W; Solomon B; Soria JC; Validire P; Besse B; Brambilla E; Brambilla C; Lantuejoul S; Lorimier P; Schneider PM; Hallek M; Pao W; Meyerson M; Sage J; Shendure J; Schneider R; Büttner R; Wolf J; Nürnberg P; Perner S; Heukamp LC; Brindle PK; Haas S; Thomas RK
    Nat Genet; 2012 Oct; 44(10):1104-10. PubMed ID: 22941188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.
    Thomas A; Lee JH; Abdullaev Z; Park KS; Pineda M; Saidkhodjaeva L; Miettinen M; Wang Y; Pack SD; Giaccone G
    J Thorac Oncol; 2014 Apr; 9(4):567-71. PubMed ID: 24736083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing.
    Iwakawa R; Kohno T; Totoki Y; Shibata T; Tsuchihara K; Mimaki S; Tsuta K; Narita Y; Nishikawa R; Noguchi M; Harris CC; Robles AI; Yamaguchi R; Imoto S; Miyano S; Totsuka H; Yoshida T; Yokota J
    Carcinogenesis; 2015 Jun; 36(6):616-21. PubMed ID: 25863124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
    Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S
    Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
    Voortman J; Lee JH; Killian JK; Suuriniemi M; Wang Y; Lucchi M; Smith WI; Meltzer P; Wang Y; Giaccone G
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13040-5. PubMed ID: 20615970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
    He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
    Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
    Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R
    Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.